-
Forward Look
Rinse and RecurrenceSaliva test can help identify people who are at high risk of recurrence after mouth or throat cancer treatment.
by Eric Fitzsimmons
-
Forward Look
Upfront Immunotherapy in Early-stage Liver CancerResearchers analyze whether giving immunotherapy before surgery benefits people with high-risk disease that is limited to the liver.
by Christina Szalinski
-
Forward Look
The Overlooked Issue of Hearing LossStudy underscores importance of regular hearing tests for those who receive cisplatin chemotherapy.
by Risa Kerslake
-
Policy Matters
Toward Improved Dosing in the Precision Oncology EraA forthcoming article series outlines considerations for the dose optimization of modern oncology drugs.
by Brad Davidson, PhD
-
Overcoming ResistancePeople with metastatic hormone receptor-positive breast cancer are living longer, thanks to new targeted therapies and endocrine therapies that can be prescribed when treatment resistance develops.
by Kendall K. Morgan
-
Liquid Biopsies: A Fast, Accurate AlternativeBlood tests can guide treatment choices, delivering results in less time than traditional biopsies.
by Stephen Ornes
-
Rural Cancer CareRural residents with cancer tend to have later diagnoses and poorer outcomes. Researchers and oncologists are working to identify and remove the barriers they face.
by Mark Ray
-
Facts and Stats
A Broader View of ResearchPeople diagnosed with cancer can participate in various kinds of studies.
by Thomas Celona
-
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
-
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona
-
Ultraproccessed Foods and Cancer RiskThe idea that ultraprocessed foods are associated with increased risk of metabolic and cardiovascular diseases is well supported, but what does the evidence reveal about these foods and cancer?
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
